Cardiac contractility modulation as a novel therapeutic approach in transthyretin amyloid cardiomyopathy to improve eligibility to stabilizer therapy: a case report.

Eur Heart J Case Rep · 2025 · PMC12836104 · PMID 41607553

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In this most recent follow-up TTE, diastolic parameters showed a trend towards improvement (E/E ́ ratio 22) together with a reduction in PASP to 44 mmHg and a stable NTproBNP level of 1812pg/mL.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.